ESR1 and breast carcinoma: In a study of 485 women with breast cancer by Colleoni et al., the ER/PR-negative group had 12.0 times (95% confidence interval: 4.93, 29.28) higher chance of achieving a pathologic CR (pCR) than patients in the ER/PR-positive or ER/PR-low group [11].